3-iodobenzylguanidine has been researched along with Psychoses in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, N; Kobayashi, K; Maeda, T; Nakano, H; Yamamori, S | 1 |
| Akiyama, N; Kobayashi, K; Koshino, Y; Nakano, H; Sumiya, H; Urata, K | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Psychoses
| Article | Year |
|---|---|
Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder; Female; Hallucinations; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Psychotic Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2015 |
Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Aged, 80 and over; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Female; Hallucinations; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Psychotic Disorders; Radiopharmaceuticals | 2010 |